MI , rheumatic heart disease, lung carcinoma , IBD, liver cirrhosis , cholelithiasis ,breast carcinoma

Reading File
Asking for Preferences
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Here is a Robbins-style pathology & morphology quick-bullet summary for all 7 conditions.

Pathology & Morphology — Quick Bullets

Source: Robbins & Kumar Basic Pathology; Robbins, Cotran & Kumar Pathologic Basis of Disease

1. Myocardial Infarction (MI)

Pathogenesis
  • Vast majority caused by acute coronary thrombosis on a disrupted/eroded atherosclerotic plaque
  • Plaque rupture → platelet aggregation → thromboxane A2/ADP/serotonin release → occlusion
  • ~10% occur without occlusive atherosclerosis (vasospasm, mural thrombi, embolism)
Types
  • Transmural - full-thickness necrosis; epicardial vessel occlusion + thrombus
  • Subendocardial - limited to inner 1/3 of myocardium; thrombus lysed before transmural spread; most vulnerable zone due to distance from epicardial vessels
Gross & Microscopic Progression
TimeGrossMicroscopy
0-4 hrsNo changeNo change (earliest: wavy fibres)
4-12 hrsSubtle pallorCoagulative necrosis begins; edema, hemorrhage
12-24 hrsPale/mottledPyknosis; neutrophil infiltration begins
1-3 daysYellow-tan pallorNeutrophils peak
3-7 daysHyperemic borderMacrophage ingestion of debris
1-3 wksDepressed, softGranulation tissue (vascularized)
>6 wksFibrous white scarDense collagen scar
Coronary artery distribution
  • LAD occlusion (40-50%): anterior LV, anterior 2/3 of septum, apex
  • RCA occlusion (30-40%): posterior/inferior LV, posterior 1/3 of septum
  • LCX occlusion (15-20%): lateral LV
Complications
  • Contractile dysfunction, arrhythmias, papillary muscle rupture (MR), free wall rupture → haemopericardium, ventricular aneurysm, mural thrombus, Dressler syndrome

2. Rheumatic Heart Disease (RHD)

Pathogenesis
  • Group A streptococcal pharyngitis → 2-3 wk delay → immune response
  • Anti-streptococcal antibodies (against M protein) cross-react with cardiac antigens (molecular mimicry)
  • CD4+ T cells + complement activation → pancarditis
  • Streptococci are absent from lesions
Acute RF Morphology (Aschoff bodies)
  • Focal inflammatory nodules in myocardium, pericardium, endocardium
  • Composed of: T lymphocytes, plasma cells, plump macrophages called Anitschkow cells (abundant cytoplasm, central chromatin condensed into a wavy ribbon = "caterpillar cells")
  • Pancarditis = all three layers involved
  • Endocarditis: fibrinoid necrosis → small 1-2 mm verrucae along valve closure lines
  • MacCallum plaques: subendocardial thickenings in left atrium (from regurgitant jets)
Chronic RHD Morphology
  • Mitral valve always involved (isolated in 2/3; mitral + aortic in 25%)
  • Leaflet thickening, commissural fusion, chordal thickening and shortening
  • "Fish mouth" / "button-hole" stenosis - fusion creates this appearance
  • Neovascularization of valve leaflets in chronic disease
  • Pulmonary valve - rarely affected

3. Lung Carcinoma

Adenocarcinoma (most common overall; more common in women/non-smokers)
  • Peripheral location; associated with pleural scars
  • Lepidic growth pattern (along alveolar walls without architectural destruction) in adenocarcinoma in situ (AIS, ≤3 cm)
  • Invasive: glandular, papillary, micropapillary, solid, or acinar patterns; desmoplasia present
Squamous Cell Carcinoma (closely linked to smoking; more common in men)
  • Central location; arises in major bronchi
  • Preceded by squamous metaplasia → dysplasia → carcinoma in situ (over years)
  • Keratin pearls + intercellular bridges (well-differentiated)
  • Large lesions may undergo central necrosis → cavitation
Small Cell Carcinoma
  • Central, pale gray mass extending into parenchyma
  • Cells: small, round to fusiform, scant cytoplasm, finely granular "salt-and-pepper" chromatin
  • Numerous mitoses; extensive necrosis
  • Azzopardi effect: DNA staining blue along vessel walls (crush artifact in biopsies)
  • Neuroendocrine markers: synaptophysin, chromogranin, CD56
  • Metastasizes early (hilar + mediastinal nodes); associated with paraneoplastic syndromes
  • Grouped with large cell neuroendocrine carcinoma in 2021 WHO Classification
Large Cell Carcinoma
  • Diagnosis of exclusion (~10%)
  • Large nuclei, prominent nucleoli, moderate cytoplasm; no squamous or glandular features
Spread: All types spread to hilar, mediastinal, scalene, cervical nodes; Virchow's node involvement (left supraclavicular) characteristic

4. Inflammatory Bowel Disease (IBD)

Crohn Disease

  • Any site from mouth to anus; most common = terminal ileum + cecum
  • Skip lesions (multiple, separated areas of disease interspersed with normal mucosa)
  • Earliest lesion: aphthous ulcers → progress to serpentine ulcers along long axis
  • Cobblestone appearance: edematous mucosa elevated around depressed ulcers
  • Transmural inflammation → intestinal wall thickening, fibrosis, strictures
  • Creeping fat: mesenteric fat adherent to serosa
  • Fissures → fistulas (to bladder, vagina, skin) or perforation
  • Microscopy: crypt abscesses, distorted crypts, noncaseating granulomas (~35% of cases) - hallmark but not required for diagnosis; may be in any layer; pseudopyloric metaplasia

Ulcerative Colitis (UC)

  • Always starts in rectum, extends proximally, continuously - no skip lesions
  • Limited to colon; pancolitis = entire colon
  • Gross: broad-based ulcers; pseudopolyps (islands of regenerating mucosa)
  • No mural thickening, no strictures (unlike Crohn); serosal surface normal
  • Microscopy: inflammation limited to mucosa and superficial submucosa; crypt abscesses; crypt distortion; no granulomas
  • Toxic megacolon: inflammation damages muscularis propria → colonic dilation → perforation risk

5. Liver Cirrhosis

Definition
  • Diffuse transformation of entire liver into regenerative parenchymal nodules surrounded by fibrous bands
Morphology
  • Gross: nodular liver surface; broad fibrous scars between bulging nodules
  • Micronodular (<3 mm, uniform) vs. macronodular (>3 mm, irregular) - alcohol typically micronodular early
  • Microscopy: regenerative nodules; portal-portal or portal-central fibrous bridging; ductular reactions (stem cell-derived duct-like structures, prominent in cirrhosis)
  • Fibrosis can regress if disease is cured (scars thin → fragment → nodules coalesce)
Common causes
  • Chronic HBV, HCV, NAFLD/NASH, alcohol-related liver disease
Complications
  • Portal hypertension → esophageal varices, ascites, splenomegaly
  • Hepatic encephalopathy (ammonia, GABA)
  • Hepatocellular carcinoma (especially in HBV, HCV, alcohol cirrhosis)
  • Coagulopathy, jaundice, pruritus, hypoalbuminemia

6. Cholelithiasis (Gallstones)

Types
TypeCompositionFrequencyColorAssociations
Cholesterol stones>50% cholesterol monohydrate80% (Western)Yellow-white/greenObesity, female sex, pregnancy, rapid weight loss, fibrates, Native Americans
Pigment stones - BlackCalcium bilirubinate (sterile bile)-BlackHemolytic anemias, cirrhosis, ileal disease
Pigment stones - BrownCalcium bilirubinate + bacteria-Brown/softBiliary infection, biliary stasis, parasites
Pathogenesis of cholesterol stones
  • Supersaturation of bile with cholesterol → nucleation → crystal growth
  • Three factors: (1) supersaturation, (2) accelerated nucleation, (3) biliary stasis
  • Cholesterol stones contain calcium salts, proteins, and bile pigments admixed
Morphology
  • Cholesterol stones: pale yellow, round to faceted, hard, may be multiple; cross-section shows radial crystalline pattern
  • Pigment stones: black - small, irregular, multiple, crumble easily; brown - soft, greasy
  • Gallbladder wall: may show chronic cholecystitis (fibrosis, Rokitansky-Aschoff sinuses), or acute cholecystitis (edema, neutrophils, mucosal necrosis)
Complications
  • Biliary colic, cholecystitis (acute/chronic), choledocholithiasis, cholangitis, gallstone ileus, Mirizzi syndrome; risk factor for gallbladder carcinoma

7. Breast Carcinoma

Carcinoma In Situ
DCIS (Ductal Carcinoma in Situ)
  • Malignant cells confined within ductal-lobular system, no basement membrane invasion
  • Comedo type (high-grade): large cells with pleomorphic nuclei, central necrosis, calcifications → linear/branching calcifications on mammography
  • Non-comedo types: cribriform, micropapillary, solid, papillary patterns
  • Paget disease of nipple = DCIS extending into nipple epidermis; associated with invasive carcinoma
LCIS (Lobular Carcinoma in Situ)
  • Monomorphic, small, discohesive cells filling the lobule; loss of E-cadherin
  • Rarely forms calcifications; usually incidental
  • Risk marker for invasive carcinoma in either breast
Invasive Carcinoma
Invasive Ductal Carcinoma (NST - No Special Type) (~70-80%)
  • Hard, gritty mass on cut section; dense fibrotic stroma (desmoplasia)
  • Forms irregular nests, cords, or glands infiltrating stroma
  • Graded by Nottingham system: tubule formation, nuclear pleomorphism, mitotic count
Invasive Lobular Carcinoma (~10-15%)
  • Single file ("Indian file") invasion through stroma; targetoid pattern around ducts
  • Loss of E-cadherin (CDH1 mutations)
  • Discohesive cells with intracytoplasmic mucin vacuoles (signet ring-like)
  • Bilateral in ~20%; may metastasize to serosal surfaces, GI tract, meninges
Special types: medullary (lymphocyte-rich), mucinous (colloid), tubular, metaplastic
Molecular Subtypes
SubtypeMarkersFeatures
Luminal AER+/PR+, HER2−, low Ki67Best prognosis
Luminal BER+, HER2+ or high Ki67Intermediate
HER2-enrichedER−, HER2+Aggressive; responds to trastuzumab
Triple-negativeER−, PR−, HER2−BRCA1-associated; basal-like; worst prognosis
Spread: axillary lymph nodes (most common); distant - lung, bone, liver, brain, adrenals

All content sourced from Robbins & Kumar Basic Pathology (10th ed., ISBN 9780323790185) and Robbins, Cotran & Kumar Pathologic Basis of Disease (ISBN 9780443264528).

Cardamon strand

Asking for Preferences
Searching the Web

cardamom strand pod uses benefits culinary medicinal

Searching the Web

cardamom whole pods strands varieties green black cooking

Cardamom - Pods / "Strands"

"Cardamom strand" refers to the whole cardamom pod - the papery outer husk (sometimes described as a strand or capsule) enclosing the aromatic seeds inside. Here is everything you need to know.

What It Is

Cardamom belongs to the ginger family (Zingiberaceae). The pod (the "strand" or capsule) is the small, papery outer shell that holds 8-16 dark brown to black seeds. The pods are roughly fingertip-sized.
There are three varieties, each with a distinct personality:
TypeSpeciesAppearanceFlavour
Green (true cardamom)Elettaria cardamomumSmall, pale green, paperySweet, floral, citrusy, minty, slightly eucalyptus-like - the most aromatic
BlackAmomum subulatumLarge (2-3 cm), dark brown, wrinkled, toughSmoky, earthy, pungent - dried over open fire pits
WhiteBleached green cardamomPale/creamMilder, more muted version of green
Green cardamom is the default in virtually every culinary context worldwide.

Culinary Uses

Whole pods (the "strand" form)
  • Added whole to rice dishes, biryanis, curries, stews, and braised meats - impart flavour while cooking, then removed before eating (like a bay leaf or whole clove)
  • Indian biryani typically uses 4 whole pods
  • Crushed and steeped in chai tea and Arabic coffee (gahwa)
Seeds (removed from pod)
  • Toasted and ground with a mortar and pestle for maximum fresh flavour
  • Used in desserts, pastries, Scandinavian breads, Indian sweets (mithai), garam masala spice blend
Ground cardamom powder
  • Convenient but loses flavour faster; used in baking, coffee, spice rubs
Key rule: A little goes a long way - cardamom is the third most expensive spice in the world after saffron and vanilla.

Flavour Profile

The aroma comes from essential oils in the seeds, primarily:
  • α-terpinyl acetate and α-terpineol - sweet, warm, floral notes
  • 1,8-cineole (eucalyptol) - the sharp, mentholated, woody impression

Health Benefits (Evidence-Based)

Based on a 2022 review in Nutrients and other research:
  • Antioxidant - rich in phenols, flavonoids, terpenoids, tannins
  • Anti-inflammatory - bioactive compounds reduce inflammatory markers
  • Digestive aid - soothes stomach, reduces bloating, relieves nausea/morning sickness
  • Blood pressure - some evidence of lipid-modifying and BP-lowering effects
  • Antimicrobial - essential oils active against certain bacteria
Note: Most human evidence is still preliminary; most robust data comes from animal/in vitro studies.

How to Use the Whole Pod (Strands)

  1. Crush lightly with the flat of a knife or mortar to crack the husk - this releases the seeds and their aroma into the dish
  2. Infuse in hot liquid (tea, coffee, simmering sauces, rice water)
  3. Remove before serving - the pod itself is fibrous and unpleasant to bite into
  4. For grinding: split pod, extract seeds, discard husk, grind seeds fresh

Storage

  • Store whole pods in an airtight container, cool and dark
  • Whole pods last up to 1 year with good flavour retention
  • Ground cardamom loses potency within a few months - buy whole pods and grind as needed for best results
This is a shared conversation. Sign in to Orris to start your own chat.